Eyecheck Announces FDA IND Clearance of STRI Formula, the First-Ever Food-Based, Combination Product in the STRI Phase 2 Clinical Trial for COVID-19 Symptoms

Eyecheck intends to initiate the Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial to evaluate STRI Formula in non-hospitalized adults with COVID-19. This trial is expected to begin in November 2021. - November 04, 2021 - Eyecheck, Inc.

Noble Paws CBD Joins Forces with Leading Pet Diabetes Brand

Noble Paws CBD Joins Forces with Leading Pet Diabetes Brand

The pet CBD brand with an ethos, Noble Paws, donates a bottle of their healing CBD to a shelter every time one is purchased. Noble Paws has joined forces with rising star pet diabetes brand, PetTest, to reach as many pets as possible and “hemp” spread the word. - November 04, 2021 - Noble Paws

PharmStars Welcomes Sumitovant Biopharma as Its Newest Member

PharmStars Welcomes Sumitovant Biopharma as Its Newest Member

PharmStars, the only pharma-focused, member-based accelerator for digital health startups, is pleased to announce that Sumitovant Biopharma has become its newest pharma member, joining existing members including Boehringer Ingelheim, Eli Lilly and Company, and Novo Nordisk. PharmStars focuses on bridging the "pharma-startup gap." PharmStars provides startups with education and mentoring to help them engage with pharma as clients and partners. - November 03, 2021 - PharmStars

Creative Biogene Offers One-Stop Customized CRISPR-Based Microbe Genome Editing Service

CRISPR Platform is a mature system developed by Creative Biogene. Services like microbe’s gene knockout and gene knock-in central to the gene-editing area can be precisely performed based on the CRISPR platform. As a popular and useful tool in microbe genome editing, the CRISPR platform always presents excellent performance and serves quality-guaranteed results in a wide range of projects. - November 03, 2021 - Creative Biogene

Families of World War II Veterans Holds 2021 Fundraising Golf Tournament

Families of World War II Veterans will hold its annual golf tournament and fundraising event on Monday, October 25, 2021 at the award-winning Trinity Forest Golf Club in Dallas, Texas, the former home of the renowned AT&T Byron Nelson tournament. This year's tournament is presented by MetLife... - October 23, 2021 - Careington

ASHP Case Study on Drugs in Short Supply Highlights MedShorts Online Marketplace

ASHP Case Study on Drugs in Short Supply Highlights MedShorts Online Marketplace

The American Society of Health-System Pharmacists (ASHP) published a case study citing financial and sourcing successes for health system pharmacies utilizing the MedShorts marketplace for direct access to drugs. The data-driven marketplace consumes and analyzes data from ASHP Drug Shortages to match pharmacy needs and alleviate shortage occurrences. Read the case study: https://www.ashp.org/products-and-services/database-licensing-and-integration/ashp-drug-shortages/medshorts-case-study - October 21, 2021 - MedShorts LLC

Swiss Start-Up HealthyCheck Transforms the Way People Monitor Their Health Directly from Home

HealthyCheck today announces the launch of its new platform to transform the way people monitor their health. HealthyCheck is a start-up that focuses on providing many laboratory tests to the user directly from home. Users enjoy an easy and convenient way to test their health and monitor long term... - October 20, 2021 - HealthyCheck

Burn Boot Camp Robinson, PA Participates in Third Annual National "Be Their Muscle" Event

National Fitness Franchise, Burn Boot Camp, Holds Nationwide Camps on October 30 Benefitting Muscular Dystrophy Association (mda.org) as Company Closes in on $1 Million Fundraising Goal. - October 18, 2021 - Burn Boot Camp Robinson, PA

Pipelinepharma Closes €1.3M Seed Round to Shift Pharmaceutical Dealmaking Online

The European B2B pharmaceutical marketplace closed a venture seed round led by Practica Capital. Iron Wolf Capital, Pandos and a group of angel investors also participated in the funding round. - October 09, 2021 - Pipelinepharma

Omni-HC Selected to Participate in “Audience Amplification” Workshop at Prestigious Global Medical Affairs Meeting

Omni Healthcare Communications has been selected by the Medical Affairs Professional Society to convene a workshop on scientific communication amplification at the MAPS 2022 Global Annual Meeting. - October 02, 2021 - Sunny Ayr Holdings

Careington CIO, Rashmi Jain, to be a Panelist at the Women in Tech Summit

Careington International Corporation proudly announces Chief Information Officer Rashmi Jain will speak at the Women in Tech Summit. This event will take place during InnoTech Dallas on Tuesday, September 28 at the Irving Convention Center. The “Lessons from the Leaders” panel... - September 30, 2021 - Careington

Careington Announces Launch of QuoteSavant, a New Insurance Comparison Service

Careington International Corporation is excited to announce the launch of QuoteSavant, a customer-first insurance comparison service, and the newest addition to its affiliate company Careington Benefit Solutions, a nationally licensed Third Party Administrator and agency. - September 22, 2021 - Careington

Cayman Chemical Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration

The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage... - September 19, 2021 - Cayman Chemical Company

AdvantaPure(R) Announces Fall Trade Show Appearances - Includes Events in the Northeast U.S.

AdvantaPure, the high purity division of NewAge Industries, will exhibit its silicone and TPE tubing and molded assemblies at the ISPE Boston Show, BioProcess International 2021, and Interphex, all taking place in September and October. AdvantaPure will also highlight its recent clean room expansion and its in-process building renovation at the events. The company is increasing its tubing manufacturing capacity to help meet demand for its Single-Use products. - September 16, 2021 - AdvantaPure

MEDraysintell Publishes the 8th Edition of Its Nuclear Medicine Report & Directory

A set of three volumes (3,100 pages) with a description of 870 products, together with a comprehensive profile of 340 companies active around the world in the radiopharmaceutical industry. - September 16, 2021 - MEDraysintell

Synformulas Presents the Scientifically Researched Potential of Its Products for the First Time at Vitafoods Europe

Common diseases such as gastrointestinal conditions and allergies are the focus of the company’s research and product development; More value is being added for further licensing and distribution partners through strong scientific research results; SYNformulas is seeking for additional distribution partners to expand its internationalization activities with its patented active complexes. - September 13, 2021 - SYNformulas

Mirror Biologics, Inc. Announces Initial Clearance for Phase II/III Clinical Trial (ALIVE) in Advanced Liver Cancer

Mirror Biologics, Inc. Announces Initial Clearance for Phase II/III Clinical Trial (ALIVE) in Advanced Liver Cancer

Mirror Biologics, Inc, (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ vaccine immunotherapy for cancer and infectious diseases where... - September 10, 2021 - Mirror Biologics, Inc.

Aelius LED Office Expansion Improves Efficiency for Cultivators Worldwide

Canadian LED Grow Light Experts Move Into New Facility - September 07, 2021 - AeliusLED

Defined Bioscience Licenses FGF2-STAB (G3) for Use in Stem Cell Media

Defined recently concluded a licensing agreement with Czech Republic-based Enantis for global use of Enantis’ patented FGF2-STAB® technology both alone and in stem cell media formulations. FGF2-STAB®, originally coined FGF2-G3, was developed by Enantis and Masaryk University, using... - August 30, 2021 - Defined Bioscience Inc.

Podcast on Vitiligo with Recouleur® Vitiligo Vitamin Creator Audrey VanStockum

The podcast entitled “The Journey with Vitiligo with Audrey VanStockum,” will air August 31, 2021 at 11:00 a.m. CST and can be heard live as well as recorded after the show on Blog Talk Radio. VanStockum will discuss treatments she tried, and how she created Recouleur. - August 25, 2021 - Supernatural Health, Inc.

Omni Healthcare Communications & Res Consortium Form Alliance to Expand Medical Affairs Capabilities

Omni Healthcare Communications (Omni-HC), a US based medical communications firm delivering solutions for today’s scientific exchange challenges, is pleased to announce the formation of a strategic alliance with Res Consortium (Res) of the United Kingdom, a cross-sector leader in digital... - August 21, 2021 - Sunny Ayr Holdings

UpSpring® Launches New U.Siip Line of Water Enhancers for Moms

UpSpring LLC, maker of clinically-backed health and wellness solutions for all stages of mom-hood, today announced it has launched U.Siip Water Enhancers with 4 key electrolytes specifically formulated for women who are pregnant or breastfeeding. - August 19, 2021 - Upspring LLC

Food is Medicinal: PRVZN CO Launches LUV Your Mood to Help Make Stress Less Stressful

Food is Medicinal: PRVZN CO Launches LUV Your Mood to Help Make Stress Less Stressful

To help people fight the negative effects of stress, global wellbeing company PRVZN CO LLC, a pioneer in the use of adaptogens, has launched LUV Your Mood. Its selection of ingredients utilizes a powerful blend of Ayurvedic medicine and modern research to create a naturally sound, science-backed supplement for its customers. The dietary supplement features nine adaptogens that support the body's ability to adapt to stress, combat fatigue, and improve mental clarity.* - August 10, 2021 - PRVZN CO LLC

ConSep II™ Filter Module, a Game Changer in Fermentation and High Temperature Cross Flow Filtration Applications

ConSep II™ Filter Module, a Game Changer in Fermentation and High Temperature Cross Flow Filtration Applications

The combination of the patented open channel design and the high temperature capabilities of the ConSep II™ filter module provide unique performance characteristics which customers describe as an "enabling technology" and "a game changer." - July 29, 2021 - SmartFlow Technologies

Malaysia Thailand Collaboration to Increase the Affordability and Accessibility of Cancer Drugs in Thailand Through Local Manufacturing

Malaysia Thailand Collaboration to Increase the Affordability and Accessibility of Cancer Drugs in Thailand Through Local Manufacturing

Strategic collaboration between Malaysia and Thailand has been announced for technology and knowledge transfer to develop R&D and manufacturing of prescription drugs in the initiative to help millions of cancer patients in ASEAN region. - July 28, 2021 - Oncogen Pharma (Malaysia) Sdn Bhd

Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute (NHLBI)

Microvascular Therapeutics (MVT) has received funds from the from the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health for its program to treat cardiovascular disease, which kills more Americans than any other disease. As a leader in fluorocarbon... - July 19, 2021 - Microvascular Therapeutics, Inc.

Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase I/II Universal Viral Vaccine Clinical Trial (ALLOPRIME) in Healthy Adults Over 65 Years Old

Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase I/II Universal Viral Vaccine Clinical Trial (ALLOPRIME) in Healthy Adults Over 65 Years Old

Mirror Biologics, Inc, (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ vaccines for cancer and infectious diseases where the active... - July 14, 2021 - Mirror Biologics, Inc.

Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase IIB Clinical Trial (STIMVAX) in Patients with Metastatic Colorectal Cancer

Mirror Biologics, Inc. Announces Initiation of AlloStim® Phase IIB Clinical Trial (STIMVAX) in Patients with Metastatic Colorectal Cancer

Mirror Biologics, Inc. (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ cancer vaccines in which the active ingredients are living... - July 09, 2021 - Mirror Biologics, Inc.

Parvus Therapeutics Announces CEO, Senior Executive, and Board of Directors Appointments

Appoints CEO, Senior Executive, and Board of Directors: Peter M. Strumph, Chief Executive Officer; Brendan Classon PhD, Executive Vice President, Research and Development; Louis Demers, Vice President of Technical Operations; Matthew J. Hogan, member of the Board of Directors - July 06, 2021 - Parvus Therapeutics U.S., Inc.

Defined Bioscience Launches with $1.5M SBIR from the NIH to Advance Stem Cell Media

Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. - July 03, 2021 - Defined Bioscience Inc.

Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021

Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021

Paras Biopharmaceuticals Highlights Company Innovations that Decode and Create Biologics Medicines for Unmet Medical Needs (Pharma Tech Outlook, USA) - June 22, 2021 - Paras Biopharmaceuticals Finland Oy

Targeted Pharmaceuticals and George Mason University Announce First-Ever Preclinical Study Using Cannabinoids in an Organoid Model

Targeted Pharmaceuticals and George Mason University Announce First-Ever Preclinical Study Using Cannabinoids in an Organoid Model

Study Examines the Effects of Cannabinoids Treating Central Nervous System (CNS) Viruses including HIV Associated Dementia - June 16, 2021 - Targeted Pharmaceuticals

GENINVO Launches Updated New Website

After months of hard work and dedication, GENINVO is pleased to announce the new and updated website launch. The primary goal of the redesign process was to create a user-focused design, add improved functionality, and provide easy access to information about GENINVO’s products and services. - June 14, 2021 - GenInvo, Inc.

PharmAbbie, Inc. Announces the Launch of a Reg D-506(c) Common Stock Offering

PharmAbbie, Inc. Announces the Launch of a Reg D-506(c) Common Stock Offering

PharmAbbie, Inc. is pleased to announce today that it will offer up to 3,191,489 shares of its Class D Common Stock at an offering price of $4.70 per share for an aggregate offering amount of $15,000,000. The shares will be offered to accredited investors only pursuant to Regulation D, Rule 506(c)... - June 09, 2021 - PharmAbbie, Inc.

Thrivous Launches Omega Cardioprotector Formula 2

Thrivous, the human enhancement company, has released Omega Cardioprotector Formula 2. Omega is an advanced geroprotector supplement that Thrivous develops to enhance heart function and circulation for better aging. Omega formula 2 combines geroprotector nutrients with the highest levels of... - June 03, 2021 - Thrivous

MADSA Joins MAREA

The Malaysian Dietary Supplement Association joins the Malaysian Recycling Alliance to assist Members to play a more meaningful role in ESG and SDG to save the planet. - May 27, 2021 - Malaysian Dietary Supplement Association

Updated Findings of COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report

2021 Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing and Changes Since 2020 - May 25, 2021 - Life Science Strategy Group, LLC

eCTD Solutions Appoints New CEO and Changes Name to Highlight Expanded Capability

Sunny Ayr Holdings, a group of healthcare product solutions companies, is pleased to announce the change of the name of eCTD Solutions Ltd. to Omni Early Development Services and the appointment of Mark Marino, MD as Partner and Chief Executive Officer of the early product development solutions provider. - May 19, 2021 - Sunny Ayr Holdings

Advanced Silicon Group Closes Seed Preferred Equity Offering and Adds Alan Watson and Sarah Kelly to Board

Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focused on developing novel biosensors, announced today the closing of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group with participation by MIT Alumni Angels of Northern California, Sidecar Angels and other private investors and the addition of two new Directors, Alan Watson, PhD, MBA and Sarah Kelly, PhD to its Board of Directors. - May 16, 2021 - Advanced Silicon Group

Cayman Develops Powerful, New Multiplex ELISA for Autoantibody Detection

Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This... - May 16, 2021 - Cayman Chemical Company

Journal of Longevity Inc. (JOL) Announces the Launch of New Nutritional Supplement Line

Journal of Longevity Inc. (JOL) Announces the Launch of New Nutritional Supplement Line

Journal of Longevity, Inc. (JOL), a nutritional supplement startup company, is excited to announce the launch of a new health supplement line available now with vitamins and powder supplements for anyone looking to pursue a healthier lifestyle. The launch includes 18 products formulated with... - May 12, 2021 - Journal Of Longevity Inc.

A New Anti-Aging Agent is Making Its Way Into Skincare, and the Results Are on Par with Many Cosmetic Procedures

A New Anti-Aging Agent is Making Its Way Into Skincare, and the Results Are on Par with Many Cosmetic Procedures

Topical NAD+ products, previously available by prescription, are exploding onto the aesthetic scene. In 2020, Avior Nutritionals, the makers of Real NAD+, released a nonprescription skincare product that boasts more than twice the amount of NAD+ as its prescription predecessor. Avior’s... - May 07, 2021 - Avior Nutritionals- NADIA Skin

MedShorts Announces Promotion of Blake Powers to President

MedShorts Announces Promotion of Blake Powers to President

MedShorts, an Orlando-based e-commerce software solution specializing in connecting pharmacies with pharmaceutical manufacturers to source short-dated and short-supply medications, announced the promotion of Blake Powers to President of the company. After serving as the company’s Chief Operating Officer over the past five years, Blake has advanced to leading the company at a time when hospitals face significant financial pressure to reduce costs within their facilities. - May 06, 2021 - MedShorts LLC

Paras Biopharmaceuticals Finland Oy is Named as One of the Top 30 Admired Companies to Watch 2021

Paras Biopharmaceuticals Finland Oy, a fast-growing, biopharmaceutical technology development company, based in Oulu, Finland, announced today that it is named as one of the top 30 admired companies to watch during 2021, by CIO Bulletin, USA. - April 28, 2021 - Paras Biopharmaceuticals Finland Oy

Linshom Receives SBIR Phase II Contract Award from the United States Air Force for Its Dual Purpose Respiratory Device

Linshom announced today receipt of a phase II SBIR contract award with the United States Air Force (USAF) to fund ongoing development and deployment of the Linshom Predictive Continuous Respiratory Monitoring (LPCRM) System. The $748K contract follows successful completion of a SBIR phase 1 award... - April 27, 2021 - Linshom

Careington Announces Completion of New Corporate Campus in Frisco

Careington International Corporation celebrated the recent completion of its new corporate campus located in Frisco, Texas. This facility is an addition to Careington’s international headquarters, which includes two buildings also located in Frisco. This new campus was developed to address... - April 23, 2021 - Careington

Court Square Group and 5thPort Announce Life Science Industry Partnership

Court Square Group and 5thPort’s Partnership helps life science companies streamline clinical trials and procedures, increase regulatory compliance, and shorten time to market. - April 15, 2021 - Court Square Group

Families of World War II Veterans Takes Part in Frisco Veteran’s 100th Birthday Celebration

Families of World War II Veterans is excited to announce it took part in a special birthday celebration in Frisco in honor of World War II veteran Burnie Sutter’s 100th birthday on Saturday, April 10. To help commemorate the birthday of this war hero, Families of World War II Veterans... - April 11, 2021 - Careington

Newest Weapon in the Fight Against COVID 19 - Bi-Polar Ionization System Tests Positive for Killing Coronavirus

The scientific study was conducted by Hylabs and followed the stringent guidelines developed by the Israeli Ministry of Health. The tests concluded that the Sterionizer D6 and D5 units were capable of inactivating hCoV-OC43; an acceptable model for SARS-CoV-2 which causes COVID-19. Medcare Medical Devices Canada is a Canadian importer and authorized distributor of the Sterionizer family of ionizer systems. They have the products registered under their MDEL license with Health Canada. - March 25, 2021 - MedCare Medical Devices Canada

Portland Trainer Attempts to Break World Record for Heaviest Weight Lifted by Kettlebell Swing

To demonstrate the incredible power of consistency and the body's ability to heal, Portland-based personal trainer and life enhancement enthusiast Steven Herrera will be continuously swinging a kettlebell through a full range of motion for an hour straight. Herrera is taking on this challenge in an effort to break the current Guinness World Record and also hopes to raise awareness for diabetes. - March 18, 2021 - Stick-To-It Fitness

Press Releases 251 - 300 of 3,160